This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethyl group, is particularly valuable in the development of drugs targeting central nervous system disorders, such as antidepressants and anxiolytics. The stereochemistry of the molecule also plays a critical role in its biological activity, making it a crucial component in the production of enantiomerically pure compounds. Additionally, its unique properties are leveraged in research for designing novel therapeutic agents with improved efficacy and reduced side effects.